IPCALAB.NS

Ipca Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,507.70

Jun 02, 2026

AI Brief

Market cap

—

52w range

—

P / E

—

EPS · FY 2026

$44.98

Volume

—

Revenue · FY 2026

$96.46B

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on Ipca Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1507.70

Change

+7.39%

Period high

$1656.20

Period low

$1404.00

Period start

$1404.002026-02-01

Through 2026-06-02

Fair value

Football field →

Weighted blend

$986.74

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for IPCALAB.NS.

Peers

No peer list available for IPCALAB.NS.

Total assets

$123.7B

Total debt

$8.09B

Cash & equiv

$5.65B

Operating CF

$11.42B

Free cash flow

$4.86B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$96.46B	$23.32B	$11.41B	$44.98	+11.83%